Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease

por Ben Bashat, Dafna, Thaler, Avner, Lerman Shacham, Hedva, Even-Sapir, Einat, Hutchison, Matthew, Evans, Karleyton C., Orr-Urterger, Avi, Cedarbaum, Jesse M., Droby, Amgad, Giladi, Nir, Mirelman, Anat, Artzi, Moran
Publicado 2022

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease

por Biondetti, Emma, Santin, Mathieu D, Valabrègue, Romain, Mangone, Graziella, Gaurav, Rahul, Pyatigorskaya, Nadya, Hutchison, Matthew, Yahia-Cherif, Lydia, Villain, Nicolas, Habert, Marie-Odile, Arnulf, Isabelle, Leu-Semenescu, Smaranda, Dodet, Pauline, Vila, Miquel, Corvol, Jean-Christophe, Vidailhet, Marie, Lehéricy, Stéphane
Publicado 2021